Home » Topics » Regulatory » Patents

Patents
RSS

New MAP4K1 inhibitors identified at Ariad Pharmaceuticals

June 29, 2018

Vertex patents CFTR modulators

June 28, 2018

Gachon University, Seoul National University identify SIRT1 activators

June 28, 2018

Ensemble Therapeutics divulges IDO-1 inhibitors

June 27, 2018

Fraunhofer-Gesellschaft describes new bacterial glutaminyl cyclase inhibitors

June 27, 2018

Merck & Co. presents HIV integrase inhibitors

June 26, 2018

Roche, Genentech describe RIP-1 inhibitors

June 26, 2018

Universitaet Hamburg divulges nucleoside triphosphate prodrug antivirals

June 26, 2018

University of KwaZulu-Natal patents isatin derivatives

June 26, 2018

Dual MetAP 2/DPP-IV inhibitors identified at Lilly

June 22, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...